PwC Report: Value and Volume of MedTech Deals Could Rise This Year
PwC recently released its Global Pharma & Life Sciences Deals Insight report. The following are some quick highlights from the report relative to the medical device sector.
The firm listed the top 12 deals in pharma and lifesciences in 2019; two medical device deals made the list. The billion-dollar acquisitions were: Acelity, Inc. by 3M and Stryker’s acquisition of Wright Medical Group.
Last year the medical device industry saw a decline in deal value and volume. The report states that medtech companies may be going back to the drawing board to internally figure out the management of payor and provider relationships before moving forward on inorganic expansion. However, PwC’s sub-sector analysis anticipates that the value and volume of deals will go up this year, including the potential for deals between $2–$5 billion in the medical device segment.
Related Articles
-
It is more important than ever for medical manufacturers to prepare for business interruption due to unexpected damage or natural disasters. From building a recovery team to securing proper insurance, there are many steps device manufacturers can take to recover…
-
Nondisclosure agreements (NDAs) can help protect trade secrets and build a framework for better cooperation and understanding between parties. Following are some key areas to consider when creating an NDA.
-
Standalone best-of-breed Enterprise Asset Management (EAM) systems have historically been leveraged to help solve the transactional needs of clinical engineering, IT and facilities. Yet few organizations are currently capitalizing on the wealth of data generated from these systems. In this…
-
Veeva Vault CRM for Medtech is a unified customer relationship management (CRM) and content management application built for medtech sales teams, key account managers and medical affairs professionals.
